Moses Lake Pharmacy Recalls Dexpantenol Injectable Solution Due to Sterility Concerns
JD & SN Inc. is recalling 6 syringes of Dexpantenol Injectable Solution because the FDA identified a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a risk of serious injury or death from infection, meeting the criteria for a Severe rating.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 6 syringes of Dexpantenol, Injectable Solution, 250 MG/ML, 30 mL. The product is prescription-only and was distributed nationwide. The recall was initiated due to a lack of assurance of sterility, which applies to all sterile human compounded drugs within their expiry date.
The FDA has classified this recall as Class II. Consumers and healthcare providers should stop using the affected product and contact the recalling firm or their healthcare provider for further instructions.
The recalled product
- Product
- DEXPANTHENOL, Injectable Solution, 250 MG/ML, 30 mL syringes, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 6
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t05282015@25
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereRXQ Compounding Recalls Dexpantenol Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereBeacon Hill Medical Pharmacy Recalls Dexpantenol Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-09-18
- SevereDexpanthenol Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2018-11-07
- SevereFDA Recalls Dexpantenol Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- SevereRed Mountain Compounding Pharmacy Recalls S-Dexpantenol Injection Vials
FDA (Drugs) · 2019-11-13
- SeverePromise Pharmacy Recalls Dexpanthenol Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-02-20